Skip to main content
Erich Sturgis, MD, Otolaryngology (ENT), Houston, TX, St. Luke's Health - Baylor St. Luke's Medical Center

ErichM.SturgisMDMPH

Otolaryngology (ENT) Houston, TX

Head & Neck Oncologic Surgery

Tenured Professor, Vice-Chair of Clinical Affairs - Baylor College of Medicine, Otolaryngology-Head and Neck Surgery

Dr. Sturgis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sturgis' full profile

Already have an account?

  • Office

    1977 BUTLER BLVD
    JAMAIL SPECIALTY CENTER - E5.200
    Houston, TX 77030
    Phone+1 713-798-5900
    Fax+1 713-798-5078
  • Is this information wrong?

Summary

  • Dr. Sturgis is board certified and a professor with tenure in the Department of Otolaryngology-Head and Neck Surgery. He is Vice-chair of Clinical Affairs, holds the Brown Foundation Endowed Chair, and is the Head Neck and Thyroid Multidisciplinary Program Director. Prior to joining Baylor College of Medicine, he served for 23 years at MD Anderson Cancer Center caring for patients with complex head, neck, and thyroid cancers- with over 4,000 surgical patients. His surgical practice is focused on thyroid cancer, sarcomas of the head and neck region, and melanoma/non-melanoma skin cancers. He has devoted much of his academic career to HPV-related oropharyngeal cancer and working to broadly disseminate the message of preventive HPV vaccination. He has founded and led several multidisciplinary translational research and outreach efforts in HPV-related cancers. He is the national Head and Neck Surgical Chair for the national cooperative group trial network, NRG Oncology. Currently, he leads a clinical trial (Houston; NCT02897427, clinicaltrials.gov) of 1500 middle-aged men to develop a novel paradigm for screening for HPV-related cancers in men. He has more than 350 peer-reviewed publications, over 60 invited reviews/book chapters, and over 230 invited lectures; and has been recognized for his efforts in cancer prevention, mentoring, and education.

Education & Training

  • The University of Texas Health Science Center School of Public Health
    The University of Texas Health Science Center School of Public HealthMaster in Public Health, 2002 - 2004
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 1999 - 2000
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Molecular Epidemiology, 1997 - 1999
  • Vrjie University
    Vrjie UniversityFellowship, Head and Neck Oncologic Surgery, 1996 - 1997
  • Tulane University
    Tulane UniversityResidency, Otolaryngology - Head and Neck Surgery, 1992 - 1996
  • New York Presbyterian Hospital (Columbia and Cornell Campus)
    New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Otolaryngology - Head and Neck Surgery, 1991 - 1992
  • Tulane University
    Tulane UniversityInternship, Surgery, 1990 - 1991
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1990, Doctor of Medicine, MD, Cum Laude Graduate
  • Louisiana State University
    Louisiana State UniversityBachelor of Science, Biochemistry, Cum Laude, 1982 - 1985

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1998 - 2025
  • LA State Medical License
    LA State Medical License 1992 - 2011
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Faculty Achievement Award in Cancer Prevention The University of Texas MD Anderson Cancer Center, 2019
  • President's Recognition of Faculty Award The University of Texas MD Anderson Cancer Center, 2019

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial  
    Kristina R. Dahlstrom, Karen S. Anderson, Ming Guo, Michael C. Kwon, Craig A. Messick, Curtis A. Pettaway, Nancy Asomaning, Marika Hopper, Anthony Price, Li Xua, Andre..., Oral Oncology, 9/2021
  • Risk and Clinical Risk Factors Associated with Late Lower Cranial Neuropathy in Long-Term Oropharyngeal Squamous Cell Carcinoma Survivors  
    Ryan P Goepfert, Stephen Y Lai, Renata Ferrarotto, Erich M Sturgis, JAMA Otolaryngology–Head & Neck Surgery
  • Considerations in Human Papillomavirus–Associated Oropharyngeal Cancer Screening  
    Carole Fakhry, Erich M Sturgis, JAMA Otolaryngology–Head & Neck Surgery
  • Join now to see all

Lectures

  • Oropharyngeal Cancer Epidemic and HPV Vaccination 
    Houston, TX - 10/27/2014

Authored Content

  • Considerations in Human Papillomavirus–Associated Oropharyngeal Cancer ScreeningMay 2020

Press Mentions

  • Preventing Throat Cancer: The Importance of Vaccination and Screening
    Preventing Throat Cancer: The Importance of Vaccination and ScreeningAugust 17th, 2021
  • Baylor Recruiting Participants for Throat Cancer Screening Study
    Baylor Recruiting Participants for Throat Cancer Screening StudyJune 14th, 2021
  • Baylor College of Medicine Recruiting Participants for Throat Cancer Screening Study
    Baylor College of Medicine Recruiting Participants for Throat Cancer Screening StudyJune 14th, 2021
  • Join now to see all

Grant Support

  • Establishment of a Prospective Cohort at Risk for HPV-Related Cancers: Using HPV Testing at Mucosal Sites and Blood-Based Assays for Risk Stratification in MenCancer Prevention & Research Institute of Texas2020–Present
  • Use Of Serum HPV16 DNA As A Marker For Oropharyngeal Cancer RecurrenceNational Cancer Institute2007–2008

Professional Memberships

Hospital Affiliations